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Adenosine Stimulates Fibroblast Growth Factor-7
Gene Expression Via Adenosine A2b Receptor
Signaling in Dermal Papilla Cells
Masato Iino1,4, Ritsuko Ehama1,4, Yosuke Nakazawa1, Tokuro Iwabuchi1, Masashi Ogo1, Masahiro Tajima2
and Seiji Arase3
It has been previously reported that an adenosine receptor-mediated signal-transduction pathway in the dermal
papilla cells (DPCs) of hair contributes to minoxidil-induced hair growth. In this study, we investigated this
hypothesis further and have elucidated some underlying mechanisms. We performed DNA microarray analyses
of DPCs and found that adenosine stimulation increases fibroblast growth factor-7 (FGF-7) gene expression
levels by greater than 2-fold. Elevations of the extracellular FGF-7 protein levels were also observed. These
upregulations of FGF-7 both at mRNA and protein levels were inhibited by A2b adenosine receptor-specific
antagonist, alloxazine, but not by antagonists for other subtypes. In addition, the intracellular cAMP levels were
raised by adenosine in a dose-dependent manner. Moreover, an increase of intracellular cAMP augmented the
FGF-7 upregulation. Taken together, these results show that adenosine treatment of DPCs upregulates FGF-7
expression via the A2b adenosine receptor and that cAMP acts as one of the second messengers in this pathway.
Furthermore, treatment with FGF-7 at concentrations of 10 ng/ml or greater significantly stimulated hair fiber
elongation in human scalp hair follicle organ cultures. These data imply that adenosine might stimulate hair
growth through FGF-7 upregulation in DPCs.
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INTRODUCTION
A series of closely coordinated epithelial–mesenchymal
interactions in skin plays a central role not only in the
organogenesis of the hair follicles, but also in the pathways
that occur during hair follicle cycling (reviewed by Botchkar-
ev and Kishimoto, 2003). The hair follicle cycle comprises
repeated periods of hair growth and hair fiber formation
(anagen), apoptosis-driven involution (catagen), and both hair
regression and hair shedding (telogen-exogen) (reviewed by
Stenn and Paus, 2001). The continuation and the transition of
each phase results from the molecular control of epithelial–-
mesenchymal interactions by factors such as Wnt, transform-
ing growth factor-b, bone morphogenetic proteins, notch,
hedgehog, fibroblast growth factors (FGFs), epidermal growth
factor, tumor necrosis factor, and the neurotrophin family.
Several studies of hair follicle organ cultures have confirmed
that insulin-like growth factor-1, hepatocyte growth factor,
and macrophage-stimulating protein stimulate hair fiber
growth via specific receptors on epithelial cells, insulin-like
growth factor-1R, c-MET, and RON, respectively (Jindo et al.,
1994; Itami et al., 1995; Rudman et al., 1997; Lindner et al.,
2000; McElwee et al., 2004). In addition, it has been shown
that transforming growth factor-b inhibits hair growth (Inui
et al., 2002; Soma et al., 2002). The stimulatory factors listed
above are now considered to be powerful inducers of hair
growth and transforming growth factor-b is believed to be the
principal modulator of the transition from the anagen phase
to the catagen phase.
Minoxidil has been reported to be a powerful inducer of
hair growth because it causes significant hypertrichosis in
humans (reviewed by Messenger and Rundegren, 2004).
Lachgar et al. (1998) previously found that the production of
vascular endothelial growth factor (VEGF) is enhanced by
minoxidil in cultured dermal papilla cells (DPCs), and
concluded that minoxidil promotes hair growth via this
induction. Li et al. (2001) have proposed a mechanism for
minoxidil-induced VEGF production by which an adenosine-
mediated signaling pathway contributes to minoxidil-induced
hair growth. Minoxidil sulfate is known to activate and open
the sulfonylurea receptors of DPCs and cause the secretion of
adenosine 50-triphosphate. Adenosine 50-triphosphate diges-
tion by ecto-ATPase increases extracellular adenosine.
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Consequently, the upregulation of VEGF in DPCs is induced
through adenosine receptor (AdoR) pathways. However, the
mechanisms of hair growth governing the production of
VEGF by minoxidil have not been clearly elucidated.
In this study, we have further elucidated AdoR signal
transduction in DPCs. Adenosine is known to have various
physiological functions, including the inhibition of lipolysis,
vasodilation, and protection against ischemic damage, that
are mediated via the up- or downregulation of cAMP, IP3, and
IP3/diacylglycerol through the G protein coupling receptors
of the four AdoR subtypes A1, A2a, A2b, and A3 (reviewed by
Fredholm et al., 2001). To further understand the molecular
basis of hair growth mechanisms, we investigated the effects
of adenosine on the expression of growth factors in cultured
DPCs derived from human scalp hair follicles. DNA
microarray analysis revealed the upregulation of several
growth factors, including fibroblast growth factor 7 (FGF-7),
following adenosine stimulation. We confirmed the increase
in FGF-7 gene and protein expression using real-time
reverse-transcription PCR (RT-PCR) and specific antibodies,
respectively. We have also characterized the intracellular
secondary signal messenger in this pathway and show that
FGF-7 stimulates hair growth in organ cultures of human hair
follicles.
RESULTS
The AdoR A2b receptor facilitates FGF-7 upregulation by
adenosine in DPCs
We performed DNA microarray analyses (on a total of 12,814
genes) of DPCs that were incubated with or without 10mM
adenosine for 4 hours. Adenosine stimulation induced over 2-
fold increases in VEGF gene expression in accordance with a
previous report (Li et al., 2001). In addition, FGF-7 gene
expression level was found to be upregulated up to 2.28- and
2.57-fold. In contrast, the expression of other FGFs or
paracrine growth factors such as FGF-1, FGF-2, FGF-9,
FGF-12, insulin-like growth factor-1, and insulin-like growth
factor-2 were not significantly affected by adenosine
treatment.
FGF-7 is one of the most abundantly induced genes during
the development of hair follicles (Werner et al., 1994) and is
considered as an important endogenous mediator of normal
hair follicle growth, development, and differentiation (Dani-
lenko et al., 1995). To confirm the upregulation of FGF-7
gene expression by adenosine stimulation of DPCs, dose
dependency was examined using quantitative real-time RT-
PCR. The expression levels of FGF-7 were found to be
significantly upregulated by concentrations of adenosine
above 10 mM and to reach a peak induction level of
approximately 3.8-fold following treatment with 300mM
adenosine (Figure 1). The median effective concentration of
adenosine (EC50) for FGF-7 gene induction was estimated
from the three independent experiments to be 26.777.8 mM.
FGF-7 protein levels in the medium of the cultured DPCs
were assayed by enzyme immunoassay and were measured
at 112.777.7 pg/ml following 50 mM adenosine stimulation
for 18 hours (Figure 2). This was significantly higher than the
control (80.975.1 pg/ml; Figure 2).
To determine the subtype of adenosine signaling receptor
(AdoR) that mediates the upregulation of FGF-7, we
employed receptor antagonists. The inhibitory effects on
FGF-7 induction by adenosine were assayed in DPCs using
specific antagonists for four types of AdoR. An AdoR A2b-
specific antagonist alloxazine (ALX, Figure 3c) significantly
suppressed the upregulation of FGF-7 following 25 mM
adenosine stimulation. In contrast, neither 8-cyclopentyl-
1,3-depropylxanthine (CPX, Figure 3a), 8-(3-chlorostyryl)
caffeine (CSC, Figure 3b) nor 3-ethyl-5-benzyl-2-methyl-6-
phenyl-4-phenylethynyl-1,4-(7)-dihydropyridine-3,5-dicar-
boxylate (MRS-1191, Figure 3d), which block the activity of
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Figure 1. FGF-7 gene expression is upregulated following adenosine
stimulation of DPCs. RNA was isolated from subconfluent cultures of DPCs
(passage 3 or 4) that had been treated with adenosine for 2 hours and
subjected to RT. Quantitative analysis of RNA was performed by real-time
PCR in a LightCycler rapid thermal cycler system. The cycle numbers
obtained for FGF-7 mRNA were normalized to GAPDH. The relative
expression data were presented as the mean values7SD of the measurements
that were normalized to the mean values obtained from control untreated
cells (n¼3). Ten mM to 3 mM of adenosine significantly stimulates FGF-7 gene
expression in a dose-dependent manner (Po0.05 in Student’s t-test). EC50 for
this upregulation was estimated to be 27.1 mM. Similar results were obtained
from two repeat experiments by using independently cultured cells, and the
average EC50 in the three experiments was 26.777.8 mM.
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Figure 2. FGF-7 induction in DPCs by adenosine is suppressed by the A2b
receptor antagonist ALX. Confluent DPCs were cultured on multi-well plates
with or without adenosine and/or ALX for 18 hours. After centrifugation,
FGF-7 levels in the supernatants were assayed by enzyme immunoassay.
The results (n¼8) presented are the mean values7SD. The P-values were
determined by the Student’s t-test from the differences between the test
samples and the positive control cells that had been treated with 50mM
adenosine alone. ***Po0.001. An independent experiment revealed similar
results (n¼ 8); the base line was 57.874.3 pg/ml. Fifty mM of adenosine
significantly induced a 1.29-fold increase (Po0.001). The addition of 5 mM
ALX resulted in 71% inhibition (Po0.01) of the adenosine-induced FGF-7
production.
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AdoR A1, A2a, and A3, respectively, has any effect upon
FGF-7 upregulation. We contend that the suppression of
adenosine-induced FGF-7 by a 500 nM dose of CPX is
attributable to the nonspecific binding of this antagonist to
AdoR A2b at concentrations above 50 nM (Linden et al.,
1999). The elevated FGF-7 protein levels in the medium of
DPCs by 50 mM adenosine were also significantly reduced by
cotreatment with 5 and 10 mM of ALX (Figure 2). These
findings suggest that an AdoR A2b-mediated signal-transduc-
tion pathway in the DPCs contributes to FGF-7 upregulation
by adenosine.
The AdoR A2b is present on hair follicles
To further examine the involvement of AdoR A2b signaling in
dermal papilla, we performed immunohistochemical staining
for this receptor on human hair follicles (Figure 4). AdoR A2b
proteins were mainly detectable on both the dermal papilla
and the outer root sheath, and were evident at lower levels on
the dermal sheath and the hair matrix cells.
cAMP acts as one of the second messengers for the FGF-7
upregulatory signaling pathway through AdoR A2b in DPCs
It has been shown that AdoR A2b generally couples with the
Gs protein or, in certain cell types, the Gq/11 protein, and
that its second messenger in these instances is cAMP and IP3/
diacylglycerol, respectively (Pierce et al., 1992; Gao et al.,
1999). To determine the identity of the second messenger that
mediates FGF-7 upregulation by adenosine in DPCs, we
analyzed the intracellular cAMP levels in these stimulated
cells by enzyme immunoassay. We subsequently observed
that the intracellular cAMP levels in DPCs were significantly
increased following 5 minutes incubation with 25 mM adeno-
sine (data not shown). Moreover, these intracellular cAMP
levels increased in a dose-dependent manner over concen-
trations of 10 mM (Figure 5a). It was noteworthy that both this
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Figure 3. The effects of different AdoR antagonists upon adenosine-stimulated FGF-7 gene upregulation in DPCs. RNA was isolated from subconfluent cultures
of DPCs (passage 3 or 4) that had been incubated with or without 25 mM adenosine and AdoR antagonists for 2 hours. Real-time RT-PCR was then performed.
Cycle numbers obtained for FGF-7 mRNA were normalized to GAPDH. Relative expression data are presented as the mean values7SD (n¼ 4), normalized to
the controls without adenosine. It is noteworthy that the (c) AdoR A2b-specific antagonist ALX, (a, b, and d) but not the antagonists specific for AdoR A1 (CPX),
A2a (CSC), or A3 (MRS-1191), suppresses the upregulation of FGF-7 gene expression. The P-values were determined by the Student’s t-test from the differences
between the test samples and the positive control cells that had been treated with 25 mM adenosine alone. *Po0.05, **Po0.01. These experiments were
repeated and generated similar results; the addition of 5 mM ALX resulted in 72% inhibition (Po0.05) of the 25 mM of adenosine-induced FGF-7 gene expression
(1.9870.49-fold increase). In contrast, the addition of CPX, CSC, or MRS-1191 generated no meaningful inhibition.
a b
Figure 4. Immunohistochemical staining of AdoR 2b on a human scalp
specimen. A human scalp specimen from a healthy 25-year-old male subject
was fixed with 10% formalin in phosphate-buffered saline, pH 7.4 and
embedded in paraffin. (a) Five mm sections were incubated with 20 mg/ml of
rabbit polyclonal antibody against human AdoR A2b (AB1589P).
(b) Substitution of the primary antibodies with normal rabbit IgG served as a
negative control and the color reactions were developed using 3,30-diamino-
benzidine. Note that AdoR A2b was mainly detectable on the dermal papilla
and the outer root sheath (indicated by arrowheads), and found to be present
at low levels on the dermal sheath and the hair matrix cells (indicted by
arrows).
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dose-dependent pattern and the estimated EC50 of
42.7717.8 mM from three independent experiments were
similar to the values measured during the upregulation of
FGF-7 gene expression in DPCs (Figure 1). Furthermore, the
specific AdoR A2b antagonist ALX suppressed the induction
of cAMP by 25 mM adenosine stimulation (Figure 5b), which
was comparable with the suppression of FGF-7 gene
upregulation by this inhibitor (Figure 3c). In contrast, the
addition of specific antagonists for AdoR A1 (CPX), A2a
(CSC), and A3 (MRS-1191) did not affect increased cAMP
level (data not shown).
If the second messenger for the FGF-7 upregulation is
cAMP, we reasoned that either cAMP analogs, or substances
that are known to elevate intracellular cAMP levels, should
also upregulate FGF-7 gene expression. We observed indeed
that an adenylate cyclase activator, forskolin, significantly
stimulates FGF-7 gene expression in a dose-dependent
manner at a concentration range of 100 nM to 1 mM (Figure 6).
A cAMP analog, dibutiryl-cAMP, also produced these effects
at doses from 10 mM to 1 mM (data not shown). Taken together,
these results indicate that cAMP is generated via the Gs
protein coupling receptor, AdoR A2b, and acts as one of the
second messengers that mediate FGF-7 upregulation in DPCs.
The effects of FGF-7 upon cultured human hair follicles
To further understand the contribution of FGF-7 during hair
growth, the effects of the human FGF-7 protein were assayed
using human anagen hair organ cultures. The addition of
10 ng/ml (Days 6 and 9), 30 ng/ml (Days 6 and 9), and 100 ng/
ml (Days 3, 4, 5, 6, and 9) of FGF-7 into the culture medium
resulted in significant hair elongation when compared with
the control cultures over 9 days (Figure 7). Moreover, the hair
follicles treated with FGF-7 maintained anagen morphology
during this 9-day period. These results indicate that FGF-7
may stimulate hair growth by inducing the proliferation and
differentiation of human hair follicular cells.
DISCUSSION
It has been reported that an adenosine-mediated signal-
transduction pathway, which is in part mediated by
intracellular Ca2þ , contributes to minoxidil-induced hair
growth. This evidence is derived from studies showing
minoxidil-induced VEGF production in cultured DPCs (Li
et al., 2001). We now show from our current experiments that
the gene expression level of FGF-7 is upregulated in cultured
DPCs by a 10 mM concentration of adenosine. FGF-7, a
glycoprotein secreted from mesenchymal cells, has a target
specificity that is restricted to the mitotic activity of epithelial
cells. In addition, as a paracrine growth factor, FGF-7
functions during the morphogenesis of epithelia, the re-
epithelialization of wounds, and during hair development
(reviewed by Danilenko, 1999). It has been shown to directly
affect the development of hair follicles (Werner et al., 1994)
and is known as its antagonistic interplay with the differ-
entiation factor, bone morphogenetic protein 2/4 (Kulessa
et al., 2000; Kobielak et al., 2003). Rosenquist and Martin
(1996) previously localized FGF-7 mRNA in the dermal
papilla of the hair follicles during anagen, whereas FGF-7
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Figure 5. Upregulation of cAMP following adenosine stimulation of DPCs.
DPCs (passage 4) were incubated with or without adenosine and AdoR
antagonists for 20 minutes at 371C. The intracellular cAMP concentration was
then determined using an enzyme immunoassay kit. The results shown
represent the mean values7SD (n¼ 6). (a) Upregulation of intracellular cAMP
levels following adenosine stimulation of DPCs. The addition of 10 mM
adenosine and above significantly increased the cAMP levels (Po0.05 by
Student’s t-test). EC50 for this upregulation was estimated to be 64.8 mM.
Similar results were obtained from two repeat experiments and the average
EC50 in the three experiments was 42.7717.8mM. (b) The effects of the AdoR
A2b-specific antagonist, ALX, upon intracellular cAMP upregulation by
adenosine. ALX concentrations of 200 nM and above significantly suppressed
the cAMP upregulation by adenosine. The P-values were determined by the
Student’s t-test from the differences between the test samples and the positive
control cells that had been treated with adenosine alone. **Po0.01,
***Po0.001. Two independent experiments revealed similar results; the base
lines were 24.070.9 and 30.175.3 fmol/104cells. Twenty-five mM of
adenosine significantly induced 2.90- and 3.55-fold increase (Po0.01). The
addition of 1 mM ALX resulted in 75 and 63% significant inhibition (Po0.05
and Po0.01, respectively) of the cAMP upregulation.
2.0
1.8
1.6
1.4
1.2
1.0
0 1 10
R
el
at
ive
 e
xp
re
ss
io
n
(F
GF
-7/
GA
PD
H 
mR
NA
)
Forskolin (nM)
100 1,000 10,000
**
**
Figure 6. FGF-7 gene expression is upregulated by forskolin stimulation of
DPCs. RNA was isolated from subconfluent cultures of DPCs (passage 3)
treated with forskolin for 2 hours, and was subjected to real-time RT-PCR. The
cycle numbers obtained for FGF-7 mRNA were normalized to GAPDH. The
relative expression data are presented as the mean values7SD (n¼4),
normalized to untreated control. Forskolin concentrations of 1 mM and higher
significantly stimulate FGF-7 gene expression in a dose-dependent manner
(**Po0.01 by Student’s t-test).
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mRNA levels were below the limits of detection elsewhere in
the skin. Further, expression was downregulated by the late
anagen VI stage.
Exogenously administered FGF-7 was previously shown to
stimulate hair growth in nu/nu athymic nude mice by
stimulating follicular proliferation and inducing normaliza-
tion of the nu/nu follicular keratin differentiation defect
(Danilenko et al., 1995). Sredni et al. (2004) also reported
that the synthetic immunomodulator AS101, ammonium
trichloro (dioxoethylene-o,o0) tellurate, stimulates hair growth
and its stimulation depends entirely on FGF-7. AS101
possesses the dual ability to both induce anagen and retard
spontaneous catagen in mice. Anagen induced by AS101 is
thought to be mediated by FGF-7, as it is abrogated both in
nude mice cotreated with AS101 plus neutralizing anti FGF-7
antibodies and in AS101-treated transgenic mice expressing
a dominant-negative FGF-7 receptor transgene in basal
keratinocytes.
FGF-7 has also been shown to inhibit the transition to
catagen shapes in hair follicle organ cultures (Philpott, 2000).
The addition of 10 ng/ml FGF-7 to hair organ culture medium
for 7 days causes a decrease (58%) in the number of follicles
in catagen when compared with the follicles (73%) in
untreated medium. In this study, the stimulation of hair fiber
elongation was observed with daily addition of 10, 30, and
100 ng/ml FGF-7 to the culture medium. Taken together,
these data suggest that FGF-7 induces and maintains hair
growth at anagen.
There are no earlier reports regarding the effect of
adenosine on hair follicle organ culture. We observed in
hair organ cultures over a period of 5 days that 1 mM (21%,
n¼14, P¼0.0066) and 100 mM (14%, n¼14, P¼ 0.0183) of
adenosine, but not 10 nM adenosine (43%, n¼14,
P¼0.3661), produced significant decreases in the ratio of
hair follicles of catagen-like shape, compared with control
follicles (64%, n¼ 14) (Y Nakazawa, unpublished data). The
anagen maintaining effects of adenosine may be due to the
effect of FGF-7 induced by adenosine on DPCs.
We also investigated the intracellular signal-transduction
mechanisms underlying adenosine stimulation of cultured
DPCs. Adenosine interacts with the four G protein-coupled
receptors, A1, A2a, A2b, and A3 (Fredholm et al., 2001). The
common effector of the response to the activation of these
receptors is adenylate cyclase, which is negatively regulated
by A1 and A3 receptors and positively regulated by A2
receptors. AdoR A2b is characterized as a ‘‘low-affinity’’
receptor for adenosine. The EC50 value for FGF-7 upregula-
tion by adenosine in DPCs was calculated to be 26.7 mM,
suggesting that the signaling receptor for this process was
AdoR A2b because it requires high concentrations of
adenosine (EC50, 5–10 mM) to facilitate the pathway (Hide
et al., 1992). In contrast, the other three AdoR subtypes are
generally activated at much lower levels (B0.1 mM). Our
competition experiments with AdoR antagonists for both
transcription and translation of FGF-7 provided evidence of
the contribution of AdoR A2b to the upregulation of this gene
by adenosine stimulation. Furthermore, immunochemical
staining of AdoR A2b in the dermal papilla of hair supports
the contention that this receptor participates in FGF-7 gene
expression in these cells in vivo.
The downstream signaling pathways of AdoR A2b in DPCs
are still somewhat unclear. The receptor is shown to be
coupled with the Gs and Gq proteins (Auchampach et al.,
1997; Linden et al., 1999) and thus contribute to the
upregulation of cAMP and IP3/diacylglycerol, respectively.
Significantly, the upregulation of cAMP through AdoR A2b
was observed following adenosine stimulation in this study.
Moreover, both forskolin and dibutiryl-cAMP caused the
upregulation of FGF-7 gene expression. These data demon-
strate that the intracellular cAMP signal pathway, at least in
part, contributes to the upregulation of FGF-7 gene by
adenosine stimulation. cAMP is a second messenger that is
produced in cells in response to growth factors, neurotrans-
mitters, and hormones. It is known that the activation of AdoR
A2b stimulates a cAMP-dependent protein kinase pathway
and thus promotes the phosphorylation of various proteins,
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Figure 7. The effects of FGF-7 upon hair elongation in follicle organ cultures
from human scalp. Anagen hair follicles were isolated from human scalp and
were incubated with recombinant human FGF-7 at concentrations of
(a, b, and c) 0 ng/ml (containing vehicle 0.01% DMSO; ’), (a) 10 ng/ml
(K), (b) 30 ng/ml (m), or (c) 100 ng/ml (&) (n¼13, in each concentration).
Increases in the length of hair fibers were measured sequentially over 9 days
with an inverted microscope that had been fitted with an eyepiece measuring
graticule. The results represent the mean7SD of the increases in hair fiber
lengths, compared with the baseline data. Statistical analyses of these data
were carried out using the Student’s t-test. *Po0.05, **Po0.01. An
independent experiment (n¼ 14–18) revealed similar results; addition of
100 ng/ml of FGF-7 significantly stimulated the hair fiber growth (Po0.05)
at Days 5, 8, and 11.
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including the transcription factor cAMP response element-
binding protein (reviewed by Mayr and Montminy, 2001). A
number of cAMP-dependent signaling pathways have been
characterized and shown to be mediated primarily by cAMP
response element-binding protein/activating transcription
factor family members, which are basic leucine zipper
transcription factors. The cAMP response element-binding
protein/activating transcription factor family of transcription
factors binds to the cAMP responsive element consensus
sequence TGACGTCA. Brauchle et al. (1994) have reported
that FGF-7 mRNA and protein expression is at low levels in
quiescent fibroblasts but is strongly induced upon serum
stimulation, suggesting the participation of at least two
different intracellular pathways involving protein kinase C
or cAMP-dependent kinase. Zhou and Finch (1999) identified
a cAMP responsive element-like regulatory element,
TGAGGTCAG between 39 and 46 bp relative to the
transcription start site of the human FGF-7 basal promoter
region, which directs gene transcription in a fibroblast-
specific manner and binds to the inducible activating
transcription factors. Hence, it would be reasonable to
predict that cAMP response element-binding protein/activat-
ing transcription factor family members are involved in the
upregulation of FGF-7 in DPCs by adenosine.
Recently, we performed a randomized clinical test for the
evaluation of adenosine as a hair growth promoter. Of the
102 Japanese men with androgenetic alopecia that we tested,
a topical adenosine lotion was significantly superior to a
control lotion in promoting an increase in thick hair
(Watanabe et al., paper submitted). Adenosine is known to
have various physiological functions such as vasodilatation,
anti-inflammation, angiogenesis, and tissue protection in
vascular or neuronal cells; however, little is known about
function in hair follicular cells (Fredholm et al., 2001). In
addition to the possibilities of the involvement of these action
by adenosine in hair growth stimulation, we concluded from
our presented data that adenosine might stimulate hair
growth by the upregulation of FGF-7 in DPCs; however,
further investigations will be needed to confirm the roles of
adenosine in hair growth in vivo.
MATERIALS AND METHODS
Reagents, tissues, and cells
Reagents containing the AdoR antagonists, CPX (Klotz et al., 1998),
CSC (Jacobson et al., 1993), ALX (Brackett and Daly, 1994), 3-ethyl-
5-benzyl-2-methyl-6-phenyl-4-phenylethynyl-1,4-(7)-dihydropyri-
dine-3,5-dicarboxylate (MRS-1191, Muller, 2001), dibuthyl-cAMP,
forskolin, and recombinant human FGF-7 protein were purchased
from SigmaTM (Sigma-Aldrich Japan KK, Tokyo, Japan). Adenosine
was purchased from Yamasa Corporation (Chiba, Japan). Scalp skin
samples were provided by volunteers with informed consent. The
subcutaneous fat portion where hair follicles reside was collected,
and anagen hair follicles were isolated. DPCs were separated from
the hair follicles and cultured in DMEM (Gibco-BRL, Invitrogen
Japan KK, Tokyo, Japan) supplemented with 10% fetal bovine serum
at 371C in the humidified atmosphere containing 5% CO2. DPCs
were subcultured after they had grown out from the papilla and
achieved subconfluence. This study was approved by the Shiseido
Ethics Committee to ensure subject protection and adhered to the
Declaration of Helsinki Principles.
DNA microarrays
Confluent DPC cultures were incubated in DMEM with or without
10 mM adenosine for 4 hours. Total RNA was extracted with ISOGEN
(Nippon Gene Co. Ltd, Tokyo, Japan) according to the manufac-
turer’s instructions. Five mg of total RNA was then amplified by in
vitro transcription (Luo et al., 1999). The amplified RNA (6 mg) was
reverse transcribed using random hexamers and aminoallyl-dUTP.
The synthesized complementary DNA was then labeled with either
N-hydroxysuccinimide ester Cy3 or Cy5 (Amersham Biosciences UK
Ltd, Buckinghamshire, UK, Hughes et al., 2001), applied to a
complementary DNA microarray (Human 1, Agilent Technologies
Inc., Palo alto, CA), and hybridized at 651C for 17 hours. After
washing, the microarray was scanned on a ScanArrayTM 5000 and
processed using QuantArrayTM software (Packard Instrument Co.,
Meriden, CT). The intensity of each spot was calibrated by
subtraction of the background signal. Global normalization methods
were used to identify the differentially expressed genes from each
microarray experiment. A gene was considered to be upregulated if
the difference between the two intensities was greater than the
background.
Real-time quantitative PCR
Subconfluent DPCs were cultured on multi-well plates with or
without adenosine and an AdoR antagonist. mRNA was extracted
with the MagNA PureTM mRNA extraction kit and the MagNA PureTM
instrument (Roche Diagnostics Ltd, Tokyo, Japan) according to the
manufacturer’s instructions (mRNA 1 cells). The mRNA preparation
was reverse-transcribed with SuperScriptTMII (Invitrogen Japan KK).
Real-time quantitative PCR was performed on a LightCyclerTM rapid
thermal cycler system using LightCyclerTM FastStart DNA master
SYBRTM green I kit (Roche Diagnostics Ltd) according to the
manufacturer’s instructions. The FGF-7-specific primers used were
as follows: 50-CATGAACACCCGGAGCACTAC-30 (forward,
NM_002009: 419–439), 50-CACTGTGTTCGACAGAAGAGTCTTC-
30 (reverse, NM_002009: 669–646). The glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) gene was used as a reference gene.
To confirm the amplification specificity, PCR products were
subjected to melting curve analysis. The expression levels of FGF-
7 were analyzed quantitatively with the LightCyclerTM analysis
software (Morrison et al., 1998). Fluorescence data were acquired at
the end of each extension cycle and the background fluorescence
was removed by setting a noise band. The crossing points, defined as
the cycle number at which all samples were exponentially
amplifying, were recalculated as relative log concentrations of
RNA. The cycle numbers with respect to FGF-7 mRNA were
normalized to GAPDH mRNA from the same extract. The mean
value7SD of the GAPDH normalized FGF-7 expression was
obtained from three or four samples in each condition. The results
are presented as the relative ratio to the control with the absence of
adenosine.
Determination of FGF-7 protein levels in cultured medium
The FGF-7 protein levels were measured by a commercial enzyme
immunoassay kit (R&D Systems Inc., Minneapolis, MN), following
the procedures provided by the supplier. Confluent DPC cultures on
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multi-well plates were treated with or without adenosine and ALX,
for 18 hours. After harvesting and centrifugation of the cells, the
supernatants were assayed immediately. The results are presented as
the mean values7SD of eight samples in each condition.
Immunohistochemical staining
A human scalp specimen of a 25-year-old healthy male subject was
fixed with 10% formalin in phosphate-buffered saline, pH 7.4 and
embedded in paraffin. Sections (5mm in thickness) were autoclaved
in 10 mM citrate buffer (pH 6.0), and treated with 0.3% hydrogen
peroxide, and then incubated with 20 mg/ml of rabbit polyclonal
antibody against human AdoR 2b (AB1589P, Chemicon, Temecula,
CA) in phosphate-buffered saline containing 12% BSA or normal
rabbit IgG (negative control). Biotin-conjugated goat anti-rabbit IgG
(Nichirei Corp., Tokyo, Japan) was used as the secondary antibody.
AdoR A2b was visualized with VECTASTAINTM Elite ABC Reagent
(Vector Laboratories, Burlingame, CA) and a 3,30-diamino-benzidine
Substrate Kit (Vector Laboratories).
cAMP assay
The DPCs were inoculated at a concentration of 3 104 cells per
well in standard 24-well plates and maintained in DMEM containing
10% fetal bovine serum for 3–4 days until they reached subcon-
fluence. The cells were then serum starved for another 24 hours.
Subsequently, the cells were incubated with or without adenosine
and an AdoR antagonist for 20 minutes at 371C. The intracellular
cAMP concentrations were determined by a cAMP enzyme
immunoassay kit (BiotrakTM cAMP EIA system, Amersham Bios-
ciences UK Ltd) according to the manufacturer’s protocol. The
results are presented as the mean values7SD of six samples in each
condition.
Human hair follicle organ cultures
Human hair follicles were isolated and cultured using the method
described by Philpott et al. (1990). Hair follicles isolated as
described above were placed in individual wells of a 24-well
multi-well plate, each maintained in 1 ml of Williams E medium
containing 100 U/ml penicillin, 100mg/ml streptomycin, and 250 ng/
ml Fungizone (basal medium) (Gibco-BRL, Invitrogen Japan KK),
supplemented with combinations of 10 ng/ml sodium selenite, 10mg/
ml transferrin, 10 ng/ml hydrocortisone, and 10 mg/ml insulin (plus
medium) at 371C in 5% CO2/95% air. Twenty-four hours later, the
medium was exchanged to basal Williams E medium with or without
human recombinant FGF-7 (10, 30, or 100 ng/ml). The same
medium was replaced every day for a further 8 days. The lengths
of the hair fibers were measured over this 9-day period using a
inverted microscope (Olympus IX70, Olympus Co., Tokyo, Japan)
with an eyepiece measuring graticle at  40 magnification.
Statistics
The differences in the data sets were analyzed by using the Student’s
t-test. P-values of o0.05 were considered to be statistically
significant. The EC50 for FGF-7 upregulation and cAMP induction
by adenosine were estimated using SAS (SAS institute Inc., Cary, NC)
statistical software.
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